Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bioanalysis|November 24, 2012
Tissue bioanalysis of biotherapeutics and drug targets to support PK/PDHendrik Neubert, Scott Fountain, Lindsay King, et al.
Pharmaceutical Research|September 2, 2003
Predicting oral absorption of drugs: a case study with a novel class of antimicrobial agentsAllen R Hilgers, Donald P Smith, John J Biermacher, et al.
JCI Insight|October 5, 2016
IL1RL1 asthma risk variants regulate airway type 2 inflammationErin D Gordon, Joe Palandra, Agata Wesolowska-Andersen, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
New antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinonesUpinder Singh, B Raju, Stuart Lam, et al.
Skeletal Muscle|April 6, 2016
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contracturesJoe N Kornegay, Daniel J Bogan, Janet R Bogan, et al.
Bioanalysis|December 7, 2019
2019 White Paper on Recent Issues in Bioanalysis: Chromatographic Assays (Part 1 - Innovation in Small Molecules and Oligonucleotides & Mass Spectrometric Method Development Strategies for Large Molecule Bioanalysis)Christine Fandozzi, Christopher Evans, Amanda Wilson, et al.
The Journal of Biological Chemistry|February 2, 2020
Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney diseaseXiaotian Zhong, Srinath Jagarlapudi, Yan Weng, et al.
Bioanalysis|November 19, 2016
2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 - Hybrid LBA/LCMS and input from regulatory agencies)An Song, Anita Lee, Fabio Garofolo, et al.
Bioanalysis|November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)Hendrik Neubert, Timothy Olah, Anita Lee, et al.
Bioanalysis|December 6, 2017
2017 White Paper: rise of hybrid LBA/LCMS immunogenicity assays (Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies' inputs)Hendrik Neubert, An Song, Anita Lee, et al.
Pageof 4